Prophylaxis of urinary tract infection in persons with recent spinal cord injury: A prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole

The American Journal of Medicine

Volumn 95, Issue 2, 1993, Pages 141-152

  Gribble, Marie J ^a   Puterman, Martin L ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; NORFLOXACIN; PLACEBO; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIURIA; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FEVER; FEMALE; FEVER; HUMAN; INTERMITTENT CATHETERIZATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RASH; SPINAL CORD INJURY; URINARY TRACT INFECTION; URINE CULTURE;

ADOLESCENT; ADULT; AGED; BACTERIURIA; BLADDER; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SEX FACTORS; SPINAL CORD INJURIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 0027214762     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(93)90254-M     Document Type: Article

References (36)

1. Management of urinary tract infection in acute paraplegic patients with special reference to the paper strip screening test for infection
2. Prevention of urinary tract infection during intermittent catheterization
3. Bacteriuria during follow-up in patients with spinal cord injury
4. Bacteriuria with fever after spinal cord injury
5. Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder
6. Evaluation of diagnostic criteria for bacteriuria in acutely spinal cord injured patients undergoing intermittent catheterization
7. Cause of death for patients with spinal cord injuries
8. Fever and infection in spinal cord injury patients
9. Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder
10. Nitrofurantoin macrocrystals prevent bacteriuria in intermittent catheterization
11. Urinary infection and complications during clean intermittent catheterization following spinal cord injury
12. Prevention of urinary tract infection during intermittent catheterization
13. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder
14. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients
15. Intermittent catheterization and low dose trimethoprim-sulfamethoxazole prophylaxis in bladder management of acute spinal cord injury patients
16. Extra-binomial variation in logistic linear models
17. Urological management in the patient with acute spinal cord injury
18. Asymptomatic significant bacteriuria in non-pregnant women. II. Response to treatment and follow-up
19. Untreated asymptomatic bacteriuria in girls II-Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections
20. Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics
21. Nosocomial urinary tract infections due to enterococcus
22. Enterococcal bacteremia: clinical features, the risk of endocarditis and management
23. In vivo vs. in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole: a pitfall
24. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid
25. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole by folinic acid
26. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis
27. Prophylaxis of recurrent urinary tract infection in female patients
28. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control
29. Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women
30. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection
31. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole